These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 6163946)

  • 1. Production and properties of immune interferon from spleen cell cultures of Toxoplasma-infected mice.
    Shirahata T; Shimizu K
    Microbiol Immunol; 1980; 24(11):1109-20. PubMed ID: 6163946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Production and properties of Toxoplasma growth inhibitory factor (Toxo-GIF) and interferon (IFN) in the lymphokines and the circulation of Toxoplasma immune mice.
    Sakurai H; Takei Y; Omata Y; Suzuki N
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1981 Dec; 251(1):134-43. PubMed ID: 6173972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mucosal and systemic cellular immune responses induced by Toxoplasma gondii antigens in cyst orally infected mice.
    Chardès T; Velge-Roussel F; Mevelec P; Mevelec MN; Buzoni-Gatel D; Bout D
    Immunology; 1993 Mar; 78(3):421-9. PubMed ID: 8478024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strains of Toxoplasma gondii used for tachyzoite antigens to stimulate spleen cells of infected mice in vitro affect cytokine responses of the cells in the culture.
    Rodgers L; Wang X; Wen X; Dunford B; Miller R; Suzuki Y
    Parasitol Res; 2005 Oct; 97(4):332-5. PubMed ID: 16001280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strain differences of interferon-generating capacity and resistance in toxoplasma-infected mice.
    Shirahata T; Mori A; Ishikawa H; Goto H
    Microbiol Immunol; 1986; 30(12):1307-16. PubMed ID: 2437433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune responses associated with early survival after peroral infection with Toxoplasma gondii.
    McLeod R; Eisenhauer P; Mack D; Brown C; Filice G; Spitalny G
    J Immunol; 1989 May; 142(9):3247-55. PubMed ID: 2496163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunity in the spleen and blood of mice immunized with irradiated Toxoplasma gondii tachyzoites.
    Zorgi NE; Galisteo AJ; Sato MN; do Nascimento N; de Andrade HF
    Med Microbiol Immunol; 2016 Aug; 205(4):297-314. PubMed ID: 26732075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contribution of nitric oxide to the host parasite equilibrium in toxoplasmosis.
    Hayashi S; Chan CC; Gazzinelli R; Roberge FG
    J Immunol; 1996 Feb; 156(4):1476-81. PubMed ID: 8568250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of immunization with tachyzoite excreted-secreted proteins in a novel susceptible mouse model (A/Sn) for Toxoplasma gondii.
    Costa-Silva TA; Meira CS; Ferreira IM; Hiramoto RM; Pereira-Chioccola VL
    Exp Parasitol; 2008 Nov; 120(3):227-34. PubMed ID: 18706414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Granule-dependent killing of Toxoplasma gondii by CD8+ T cells.
    Nakano Y; Hisaeda H; Sakai T; Zhang M; Maekawa Y; Zhang T; Nishitani M; Ishikawa H; Himeno K
    Immunology; 2001 Nov; 104(3):289-98. PubMed ID: 11722643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BALB/c mice resistant to Toxoplasma gondii infection proved to be highly susceptible when previously infected with Myocoptes musculinus fur mites.
    Welter A; Mineo JR; de Oliveira Silva DA; Lourenço EV; Vieira Ferro EA; Roque-Barreira MC; Maria da Silva N
    Int J Exp Pathol; 2007 Oct; 88(5):325-35. PubMed ID: 17877534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Susceptibility to re-infection in C57BL/6 mice with recombinant strains of Toxoplasma gondii.
    Brandão GP; Melo MN; Caetano BC; Carneiro CM; Silva LA; Vitor RW
    Exp Parasitol; 2011 Aug; 128(4):433-7. PubMed ID: 21640105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant canine adenovirus type-2 expressing TgROP16 provides partial protection against acute Toxoplasma gondii infection in mice.
    Li XZ; Lv L; Zhang X; Anchang KY; Abdullahi AY; Tu L; Wang X; Xia L; Zhang XX; Feng W; Lu C; Li S; Yuan ZG
    Infect Genet Evol; 2016 Nov; 45():447-453. PubMed ID: 27742446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antigen-specific (p30) mouse CD8+ T cells are cytotoxic against Toxoplasma gondii-infected peritoneal macrophages.
    Kasper LH; Khan IA; Ely KH; Buelow R; Boothroyd JC
    J Immunol; 1992 Mar; 148(5):1493-8. PubMed ID: 1538132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cold stress-induced modulation of cell immunity during acute Toxoplasma gondii infection in mice.
    Banerjee SK; Aviles H; Fox MT; Monroy FP
    J Parasitol; 1999 Jun; 85(3):442-7. PubMed ID: 10386435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of iNOS inhibitor on IFN-gamma production and apoptosis of splenocytes in genetically different strains of mice infected with Toxoplasma gondii.
    Kang KM; Lee GS; Lee JH; Choi IW; Shin DW; Lee YH
    Korean J Parasitol; 2004 Dec; 42(4):175-83. PubMed ID: 15591835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD8+ T cells from mice vaccinated against Toxoplasma gondii are cytotoxic for parasite-infected or antigen-pulsed host cells.
    Hakim FT; Gazzinelli RT; Denkers E; Hieny S; Shearer GM; Sher A
    J Immunol; 1991 Oct; 147(7):2310-6. PubMed ID: 1918963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macrophage-mediated suppression of immune responses in Toxoplasma-infected mice. III. Suppression of antibody responses to parasite itself.
    Suzuki Y; Joh K; Kobayashi A
    Cell Immunol; 1987 Dec; 110(2):218-25. PubMed ID: 3690676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune response in a murine model of congenital toxoplasmosis: increased susceptibility of pregnant mice and transplacental passage of Toxoplasma gondii are type 2-dependent.
    Thouvenin M; Candolfi E; Villard O; Klein JP; Kien T
    Parassitologia; 1997 Dec; 39(4):279-83. PubMed ID: 9802080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Both lymphotoxin-alpha and TNF are crucial for control of Toxoplasma gondii in the central nervous system.
    Schlüter D; Kwok LY; Lütjen S; Soltek S; Hoffmann S; Körner H; Deckert M
    J Immunol; 2003 Jun; 170(12):6172-82. PubMed ID: 12794148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.